2022
DOI: 10.1016/j.envpol.2022.120080
|View full text |Cite
|
Sign up to set email alerts
|

Ractopamine at legal residue dosage accelerates atherosclerosis by inducing endothelial dysfunction and promoting macrophage foam cell formation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 48 publications
0
2
0
Order By: Relevance
“…Thus, HUA triggers apoptosis as a booster, rather than a starting factor. Furthermore, blood lipids play an important role in the development of atherosclerosis 31,32) . In this experiment, there was no significant change in blood lipid; thus, UA may have contributed directly to the progression of atherosclerosis rather than by affecting lipids.…”
Section: Conflicts Of Interestmentioning
confidence: 99%
“…Thus, HUA triggers apoptosis as a booster, rather than a starting factor. Furthermore, blood lipids play an important role in the development of atherosclerosis 31,32) . In this experiment, there was no significant change in blood lipid; thus, UA may have contributed directly to the progression of atherosclerosis rather than by affecting lipids.…”
Section: Conflicts Of Interestmentioning
confidence: 99%
“…In contrast, ingestion of dietary food with an excessive β‐agonist residues will result in nausea, dizziness, muscle trembling, and heart palpitation [12]. Ractopamine at a legal residue dosage could accelerate the progression of atherosclerosis by inducing endothelial cell dysfunction and deregulating the cholesterol metabolism of macrophages [13]. Clenbuterol administration enlarged the stroke volume in a middle cerebral artery occlusion stroke model in mice [14].…”
Section: Introductionmentioning
confidence: 99%